About this event

  • Date and time Fri 21 Oct 2022 from 6:15pm to 8:10pm
  • Location Royal Society of Medicine
  • Organised by Obstetrics and Gynaecology

Free for all

Pregnant women are excluded from the benefits of many drugs because they are routinely excluded from drug trials. This exclusion leads to needless suffering and deaths of pregnant women and their babies. The recent COVID pandemic has highlighted the urgent need to address this issue.

This in-person event will discuss how to tackle the exclusion of pregnant women from drug trials.

Participants will:

  • Learn how pregnant women have been systematically excluded from drug and vaccine trials, for example, the early COVID vaccine trials.
  • Understand how this exclusion has disadvantaged and continues to disadvantage pregnant women and their babies.
  • Appreciate how this situation can be rectified.

This event is available to attend in person or virtually. Please select your preference below.

A recording will be available for all registered delegates for up to 60 days after the event. The link will be sent 24 hours after the meeting.

Follow us on:

Facebook
Instagram
LinkedIn
Twitter
YouTube

This meeting is free to attend due to generous funding from AK Fetal Medicine Ltd. Please note that the main scientific programme and content has not been influenced in any way by the organisation listed above.

Show Virtual / In Person rates

Agenda

View the programme (In person)

Registration and drinks reception
Tea and coffee break
Welcome and introduction

Professor Sadaf Ghaem-Maghami, Outgoing President, Obstetrics and Gynaecology Section, Royal Society of Medicine 

Vote of thanks to outgoing president, Professor Sadaf Ghaem-Maghami

Professor Mark Brincat

Introduction to the incoming president, Mr Pat O’Brien

Mr Eddie Morris, President, Royal College of Obstetricians and Gynaecologists

COVID-19: The exclusion of pregnant people

Mr Pat O’Brien, Incoming President, Obstetrics and Gynaecology Section, Royal Society of Medicine and Consultant, Obstetrics and Gynaecology, University College London Hospitals

The challenges of drug development in pregnancy

Professor Anna David, Obstetrics & Foetal Medicine and Director, Elizabeth Garrett Anderson Institute for Women’s Health, University College London

Medicines in pregnancy: A proposal for UK leadership

Professor Peter Brocklehurst, Women’s Health and Director, Research and Development, Birmingham Clinical Trials Unit

Questions and answers
Close of meeting
View the programme (Virtual)

Welcome and introduction

Professor Sadaf Ghaem-Maghami, Outgoing President, Obstetrics and Gynaecology Section, Royal Society of Medicine

Vote of thanks to outgoing president, Professor Sadaf Ghaem-Maghami

Professor Mark Brincat

Introduction to the incoming president, Mr Pat O’Brien

Mr Eddie Morris, President, Royal College of Obstetricians and Gynaecologists

COVID-19: The exclusion of pregnant people

Mr Pat O’Brien, Incoming President, Obstetrics and Gynaecology Section, Royal Society of Medicine and Consultant, Obstetrics and Gynaecology, University College London Hospitals

The challenges of drug development in pregnancy

Professor Anna David, Obstetrics & Foetal Medicine and Director, Elizabeth Garrett Anderson Institute for Women’s Health, University College London

Medicines in pregnancy: A proposal for UK leadership

Professor Peter Brocklehurst, Women’s Health and Director, Research and Development, Birmingham Clinical Trials Unit 

Questions and answers
Close of meeting

Location

Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom

Registration for this event will close on 20 October 2022 at 1:00am (GMT). Late registrations will not be accepted.

The agenda is subject to change at any time

All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations.

We are only able to share presentations that we have received permission to share. This is at the presenter and the RSM’s discretion.

This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.